New Medication Effective Against Chronic Hives

Sunday, 06 Oct 2013 10:10 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Swiss drugmaker Novartis said on Saturday its drug omalizumab was almost doubly effective in improving quality of life for patients with a severe form of hives, compared with a placebo, according to a late-stage study.

The third and final late-stage study of omalizumab for treating the skin disease chronic spontaneous urticaria (CSU) found the drug was nearly twice as effective versus a placebo in improving life quality within 12 weeks of treatment, while also significantly reducing itch and hives caused by the condition.

Novartis said it had filed applications for the approval of omalizumab for treating patients with CSU to U.S. and European Union health authorities in the third quarter.
 
Omalizumab, which is also known as Xolair, is already approved for treating severe asthma.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Grass-Fed Milk: Better Than Organic?

Thursday, 31 Jul 2014 15:32 PM

Health-conscious consumers are increasingly choosing a new bovine beverage many believe is healthier than organic milk:  . . .

CDC Warns Against Travel to Ebola-Stricken Countries

Thursday, 31 Jul 2014 13:42 PM

U.S. health officials are warning Americans not to travel to the three African countries hit by an outbreak of Ebola. < . . .

10 Worst States for Healthcare: Survey

Thursday, 31 Jul 2014 13:06 PM

How much bang are you getting for your healthcare buck? The answer may depend on where you live, a new study finds. . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved